Researchers report the loss of a gene called p63 accelerates aging in mice, with similar genes present in many organisms, including humans.
The scientists say mice born without the p63 gene do not survive. In previous studies, Alea Mills of Cold Spring Harbor Laboratory, found mice born with only one copy of the gene die at a young age.
To study p63 function in adult mice, Mills and colleagues devised a sophisticated molecular genetic technique enabling them to eliminate both copies of the gene from particular tissues after the animals reached maturity.
The effects of premature aging observed in the p63 deficient mice included hair loss, reduced fitness and shortened lifespan.
"Aging and cancer are two sides of the same coin," said Mills. "In one case, cells stop dividing and in the other, they can't stop dividing. We suspect having the right amount of the p63 protein in the right cells at the right time creates a balance that enables organisms to live relatively cancer-free for a reasonably long time."
The study appears in the journal Genes & Development.
Copyright 2005 by United Press International
Related stories:
Cells lining milk ducts hold key to spread of common form of breast cancer
When a form of cancer that begins in the milk ducts of the breast invades neighboring tissue to spread to other parts of the body, the cause lies not in the tumor cells themselves but in a group of abnormal surrounding cells that cause the walls of the duct to deteriorate like a rusty pipe, according to a new study led by Dana-Farber Cancer Institute researchers.
Embryonic heart exhibits impressive regenerative capacity
A new study demonstrates that the embryonic mouse heart has an astounding capacity to regenerate, a phenomenon previously observed only in non-mammalian species. The research, published by Cell Press in the October 14th issue of the journal
Developmental Cell, describes the previously unrecognized potential of the embryonic heart to replace diseased tissue through compensatory proliferation of healthy cells.
Researcher eliminates viral vector in stem cell reprogramming
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology.
Clue to genetic cause of fatal birth defect
A novel enzyme may play a major role in anencephaly, offering hope for a genetic test or even therapy for the rare fatal birth defect in which the brain fails to develop, according to a study from researchers at the University of Illinois at Chicago College of Medicine.
Mouse studies suggest daily dose of ginkgo may prevent brain cell damage after a stroke
Working with genetically engineered mice, researchers at Johns Hopkins have shown that daily doses of a standardized extract from the leaves of the ginkgo tree can prevent or reduce brain damage after an induced stroke.
RNA molecules boost vaccine effectiveness
(PhysOrg.com) -- A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Time of day influences yield for pharmacologically stimulated stem cell mobilization
A new study uncovers a previously unrecognized, species-specific impact of circadian rhythms on the production of mobilized stem cells. The research, published by Cell Press in the October 9th issue of the journal
Cell Stem Cell, suggests that when it comes to collecting human stem cells for clinical transplantation, picking the right time of day to harvest cells may result in a greater yield.
Scientists pinpoint key proteins in blood stem cell replication
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules.